The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
Open accessAbstract
Background— Separate multivariable risk algorithms are commonly used to assess risk of specific atherosclerotic cardiovascular disease (CVD) events, ie, coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure. The present report presents a single multivariable risk function that predicts risk of developing all CVD and of its constituents. Methods and Results— We used Cox proportional-hazards regression to evaluate the risk of developing a first CVD event in 8491 Framingham study participants (mean age, 49 years; 4522 women) who attended a routine examination between 30 and 74 years of age and were free of CVD. Sex-specific multivariable risk functions (“general CVD” algorithms) were derived that incorporated age, total and high-density lipoprotein cholesterol, systolic blood pressure, treatment for hypertension, smoking, and diabetes status. We assessed the performance of the general CVD algorithms for predicting individual CVD events (coronary heart disease, stroke, peripheral artery disease, or heart failure). Over 12 years of follow-up, 1174 participants (456 women) developed a first CVD event. All traditional risk factors evaluated predicted CVD risk (multivariable-adjusted P <0.0001). The general CVD algorithm demonstrated good discrimination (C statistic, 0.763 [men] and 0.793 [women]) and calibration. Simple adjustments to the general CVD risk algorithms allowed estimation of the risks of each CVD component. Two simple risk scores are presented, 1 based on all traditional risk factors and the other based on non–laboratory-based predictors. Conclusions— A sex-specific multivariable risk factor algorithm can be conveniently used to assess general CVD risk and risk of individual CVD events (coronary, cerebrovascular, and peripheral arterial disease and heart failure). The estimated absolute CVD event rates can be used to quantify risk and to guide preventive care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The predicted 10-year CVD risk score was calculated using the BMI-based sex-specific risk equations (supplementary material online, Methods), which were developed from the Framingham Heart Study by D’Agostino et al.15”
From Tirzepatide compared with semaglutide and 10-year cardiovascular disease risk reduction in obesity: post-hoc analysis of the SURMOUNT-5 trial (2025) · cites this paper as [15]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The CAC score was measured manually by expert readers using the method by Agatston and Janowitz5,6 on dedicated workstations, as reported in the parent FHS17, PROMISE19, and ROMICAT-II20 studies.”
From Deep convolutional neural networks to predict cardiovascular risk from computed tomography (2021) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“Many risk assessment systems are available and have been comprehensively reviewed, including different Framingham models, 41 Systemic Coronary Risk Estimation (SCORE), 42 ASSIGN (CV risk estimation model from the Scottish Intercollegiate Guidelines Network), 43 Q-Risk, 44 Prospective Cardiovascular Munster Study (PROCAM), 45 Reynolds, 46,47 CUORE, 48 the Pooled Cohort equations 49 and Globorisk. 5”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [41]
In the citing paper
“According to a recent large-scale cross-sectional study conducted in Japan on visceral fat area and accumulated risk factors, the average number of obesity-related cardiovascular risk factors (dyslipidemia, high blood pressure, and high blood glucose) was more than 1.0 at 100 cm2 for visceral fat area in both men and women330).”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [330]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Self-citationPencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Self-citationLopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Flagged first, then by citations
Cited by
Sorted by citations
Items 1,001–1,055 of 1,055
Suri, J. S., Bhagawati, M., Paul, S., Protogerou, A. D., Sfikakis, P. P., Kitas, G. D., Khanna, N. N., Ruzsa, Z., Sharma, A. M., Saxena, S., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12030722 · Cited by 55
Singh, S. S., Pilkerton, C. S., Shrader, C. D., & Frisbee, S. J. (2018) · BMC Public Health · doi:10.1186/s12889-018-5263-6 · Cited by 53
Yatsuya, H., Iso, H., Yamagishi, K., Kokubo, Y., Saito, I., Suzuki, K., Sawada, N., Inoue, M., & Tsugane, S. (2013) · Stroke · doi:10.1161/strokeaha.111.677534 · Cited by 56
Mistry, H., Morris, S., Dyer, M., Kotseva, K., Wood, D., & Buxton, M. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001029 · Cited by 48
Metabolic syndrome and chronic disease
Rao, D., Dai, S., Lagacé, R., & Krewski, M. (2014) · Chronic Diseases and Injuries in Canada · doi:10.24095/hpcdp.34.1.06 · Cited by 53
Value of Lifestyle Intervention to Prevent Diabetes and Sequelae
Dall, T. M., Storm, M. V., Semilla, A. P., Wintfeld, N., O’Grady, M., & Venkat Narayan, K. M. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.10.003 · Cited by 53
Is age really a non-modifiable cardiovascular risk factor?
Kannel, W. B., & Vasan, R. S. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.06.051 · Cited by 51
Self-citationMerriel, S. W. D., Andrews, V., & Salisbury, C. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.04.001 · Cited by 51
Silveira, D. V., Marcolino, M. S., Machado, E. L., Ferreira, C. G., Alkmim, M. B. M., Resende, E. S., Carvalho, B. C., Antunes, A. P., & Ribeiro, A. L. P. (2019) · JMIR mHealth and uHealth · doi:10.2196/mhealth.9869 · Cited by 51
Kadota, A., Miura, K., Okamura, T., Fujiyoshi, A., Ohkubo, T., Kadowaki, T., Takashima, N., Hisamatsu, T., Nakamura, Y., Kasagi, F., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17244 · Cited by 51
DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Herman, A. B., Tsitsipatis, D., Anerillas, C., Mazan-Mamczarz, K., Carr, A. E., Gregg, J. M., Wang, M., Zhang, J., Michel, M., Henry-Smith, C. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165933 · Cited by 50
Yatsuya, H., Iso, H., Li, Y., Yamagishi, K., Kokubo, Y., Saito, I., Sawada, N., Inoue, M., & Tsugane, S. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0081 · Cited by 47
Sex- and gender-related risk factor burden in patients with premature acute coronary syndrome
Choi, J., Daskalopoulou, S. S., Thanassoulis, G., Karp, I., Pelletier, R., Behlouli, H., & Pilote, L. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.07.674 · Cited by 68
The effect of a dietary portfolio compared to a DASH-type diet on blood pressure
Jenkins, D. J. A., Jones, P. J., Frohlich, J., Lamarche, B., Ireland, C., Nishi, S. K., Srichaikul, K., Galange, P., Pellini, C., Faulkner, D., et al. (2015) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.08.006 · Cited by 45
Brouwer, T. F., Vehmeijer, J. T., Kalkman, D. N., Berger, W. R., van den Born, B.-J. H., Peters, R. J., & Knops, R. E. (2018) · Diabetes Care · doi:10.2337/dc17-1722 · Cited by 44
James, S.-N., Chiou, Y.-J., Fatih, N., Needham, L. P., Schott, J. M., & Richards, M. (2023) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-329955 · Cited by 46
Lei, M.-K., Beach, S. R. H., & Simons, R. L. (2018) · Development and Psychopathology · doi:10.1017/s0954579418000937 · Cited by 44
Brellenthin, A. G., Lanningham-Foster, L. M., Kohut, M. L., Li, Y., Church, T. S., Blair, S. N., & Lee, D.-C. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.08.008 · Cited by 43
Park, K., Wei, J., Minissian, M., Bairey Merz, C. N., & Pepine, C. J. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6597-2 · Cited by 40
Danielsen, A. A., Fenger, M. H. J., Østergaard, S. D., Nielbo, K. L., & Mors, O. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13061 · Cited by 38
Wong, N. D., Chuang, J., Zhao, Y., & Rosenblit, P. D. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.05.003 · Cited by 39
Elbaz, A., Shipley, M. J., Nabi, H., Brunner, E. J., Kivimaki, M., & Singh-Manoux, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.051 · Cited by 38
Guo, F., & Garvey, W. T. (2017) · Diabetes Care · doi:10.2337/dc17-0088 · Cited by 37
The Measurable Benefits of a Workplace Wellness Program in Canada: Results After One Year
Lowensteyn, I., Berberian, V., Belisle, P., DaCosta, D., Joseph, L., & Grover, S. A. (2018) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0000000000001240 · Cited by 36
Regional associations of white matter hyperintensities and early cortical amyloid pathology
Lorenzini, L., Ansems, L. T., Lopes Alves, I., Ingala, S., Vállez García, D., Tomassen, J., Sudre, C., Salvadó, G., Shekari, M., Operto, G., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac150 · Cited by 36
LeBlanc, S., Coulombe, F., Bertrand, O. F., Bibeau, K., Pibarot, P., Marette, A., Alméras, N., Lemieux, I., Després, J., & Larose, E. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008139 · Cited by 35
Review on cardiovascular risk prediction
Ruwanpathirana, T., Owen, A., & Reid, C. M. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12110 · Cited by 31
Osborne, K. J., & Mittal, V. A. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.06.034 · Cited by 31
Atlas, S. J., Kim, K., Nhan, E., Touchette, D. R., Moradi, A., Agboola, F., Rind, D. M., Beaudoin, F. L., & Pearson, S. D. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.29.5.569 · Cited by 33
Zhang, H., Sachdev, P. S., Wen, W., Crawford, J. D., Brodaty, H., Baune, B. T., Kochan, N. A., Slavin, M. J., Reppermund, S., Kang, K., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.008 · Cited by 32
Wang, J., Lam, R. W., Ho, K., Attridge, M., Lashewicz, B. M., Patten, S. B., Marchand, A., Aiken, A., Schmitz, N., Gundu, S., et al. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.5685 · Cited by 30
Klein, N. S., Holtman, G. A., Bockting, C. L. H., Heymans, M. W., & Burger, H. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.06.006 · Cited by 29
Bebu, I., Braffett, B. H., Schade, D., Sivitz, W., Malone, J. I., Pop-Busui, R., Lorenzi, G. M., Lee, P., Trapani, V. R., Wallia, A., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0226 · Cited by 29
Lévesque, V., Poirier, P., Després, J.-P., & Alméras, N. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.008 · Cited by 25
Stemmer, A., Shadmi, R., Bregman-Amitai, O., Chettrit, D., Blagev, D., Orlovsky, M., Deutsch, L., & Elnekave, E. (2020) · PLOS ONE · doi:10.1371/journal.pone.0236021 · Cited by 27
Rodríguez-Martín, C., Garcia-Ortiz, L., Rodriguez-Sanchez, E., Martin-Cantera, C., Soriano-Cano, A., Arietaleanizbeaskoa, M. S., Magdalena-Belio, J. F., Menendez-Suarez, M., Maderuelo-Fernandez, J. A., Lugones-Sanchez, C., et al. (2019) · Nutrients · doi:10.3390/nu11040742 · Cited by 26
Treatment effect prediction with adversarial deep learning using electronic health records
Chu, J., Dong, W., Wang, J., He, K., & Huang, Z. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01151-9 · Cited by 24
McAlister, F. A., Robitaille, C., Gillespie, C., Yuan, K., Rao, D. P., Grover, S., Dai, S., Johansen, H., Joffres, M., Loustalot, F., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.12.004 · Cited by 25
Syncope causes transient focal neurological symptoms
Ryan, D. J., Harbison, J. A., Meaney, J. F., Rice, C. P., King-Kallimanis, B., & Kenny, R. A. (2015) · QJM · doi:10.1093/qjmed/hcv005 · Cited by 25
Mamas, M. A., Bays, H., Li, R., Upadhyay, N., Irani, T., Senyucel, C., Dunn, J. P., & Liu-Seifert, H. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf117 · Cited by 24
Cardiovascular Health and Mitochondrial Function: Testing an Association
Zampino, M., Spencer, R. G., Fishbein, K. W., Simonsick, E. M., & Ferrucci, L. (2021) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glaa297 · Cited by 20
Kim, C.-J., Schlenk, E. A., Kang, S.-W., & Park, J.-B. (2015) · Patient Education and Counseling · doi:10.1016/j.pec.2014.10.013 · Cited by 19
Rosales, C. B., Denman, C. A., Bell, M. L., Cornejo, E., Ingram, M., del Carmen Castro Vásquez, M., Gonzalez-Fagoaga, J. E., Aceves, B., Nuño, T., Anderson, E. J., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab072 · Cited by 15
Daumit, G. L., Evins, A. E., Cather, C., Dalcin, A. T., Dickerson, F. B., Miller, E. R., Appel, L. J., Jerome, G. J., McCann, U., Ford, D. E., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.1691 · Cited by 13
The Health and Economic Impact of Expanding Home Blood Pressure Monitoring
Li, Y., Zhang, D., Li, W., Chen, Z., Thapa, J., Mu, L., Zhu, H., Dong, Y., Li, L., & Pagán, J. A. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.05.010 · Cited by 11
Loebel, A., Siu, C., Rajagopalan, K., Pikalov, A., Cucchiaro, J., & Ketter, T. A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.033 · Cited by 11
Qiao, Q., Gao, W., Laatikainen, T., & Vartiainen, E. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00692.x · Cited by 9
Lee, K. (2021) · European Journal of Cancer Care · doi:10.1111/ecc.13365 · Cited by 8
Bone marrow-derived progenitor cells are functionally impaired in ischemic heart disease
Nollet, E., Hoymans, V. Y., Rodrigus, I. R., De Bock, D., Dom, M., Vanassche, B., Van Hoof, V. O. M., Cools, N., Van Ackeren, K., Wouters, K., et al. (2016) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-016-9707-z · Cited by 8
Zuo, Y., Fan, J., Sarode, R., Zhang, S., Makris, U. E., Karp, D. R., & Shen, Y.-M. (2018) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029618755946 · Cited by 7
Artificial Intelligence Electrocardiogram and Left Ventricular Systolic Dysfunction in Kenya
Pandey, A., Keshvani, N., Segar, M. W., Kwon, J.-M., Lee, H. S., Bhograj, C., Mashilane, K. I., Jain, N., Mwiti, W., Wambari, E., et al. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.0908 · Cited by 7
Folks, B., LeBlanc, W. G., Staton, E. W., & Pace, W. D. (2011) · Implementation Science · doi:10.1186/1748-5908-6-65 · Cited by 5
Wong, N. D., Karthikeyan, H., & Fan, W. (2025) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07583-z · Cited by 3
“…given that weight reduction was the primary endpoint in the SURMOUNT-1 trial, a sensitivity analysis was done using the laboratory-based equations [13] (Appendix) and the respective SURMOUNT-1 trial effects on total and high-density lipoprotein-cholesterol (HDL-C) (of − 7.4% and + 8.2%,…”
InfluentialRivas, J., Miranda, C., Restrepo, A., Hernández, M., Erazo, J. M., Martínez, M. J., Lasso, J., López, L., & Gómez-Mesa, J. E. (2025) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v53i4.1904 · Cited by 2
Liu, K., Colangelo, L. A., Daviglus, M. L., Goff, D. C., Pletcher, M., Schreiner, P. J., Sibley, C. T., Burke, G. L., Post, W. S., Michos, E. D., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002275 · Cited by 128
Metadata
- Authors
- D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B.
- Affiliations
- Boston University (US)
- Venue
- Circulation
- Published
- 2008-02-12
- Volume
- 117
- Issue
- 6
- Pages
- 743-753
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2148092884
- Cited by
- 7,491
- References
- 52
- Citations by year
- 2026: 491 · 2025: 567 · 2024: 552 · 2023: 511 · 2022: 529 · 2021: 592 · 2020: 562 · 2019: 454 · 2018: 475 · 2017: 452 · 2016: 385 · 2015: 389 · 2014: 391 · 2013: 323 · 2012: 294
- FWCI
- 169.19
- Type
- journal article
- Language
- en
- Update notices
- correction (2008-07-22)
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (2K24 HL 04334, N01‐HC25195, K24HL004334)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- cardiovascular risk prediction, atherosclerotic cardiovascular disease, Framingham risk score, coronary artery disease, stroke, peripheral arterial disease, heart failure, traditional risk factors, cholesterol, blood pressure, smoking, diabetes mellitus, primary care
- MeSH terms
- Adult, Aged, Algorithms, Cardiovascular Diseases, Female, Humans, Longitudinal Studies, Male, Middle Aged, Primary Health Care, Risk Factors, Sex Factors, Multivariate Analysis, Proportional Hazards Models, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
